Bowen; J. Phillip

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bowen; J. Phillip.The latest application filed is for "nadph oxidase inhibitors and uses thereof".

Company Profile

1.8.6

Bowen; J. Phillip - Atlanta GA
Bowen; J. Phillip - Hull GA
Bowen; J. Phillip - Greensboro NC

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
NADPH oxidase inhibitors and uses thereof Grant 11,236,053 - Guner , et al. February 1, 2	2022-02-01
NADPH Oxidase Inhibitors and Uses Thereof App 20200270214 - Guner; Osman ; et al.	2020-08-27
Solenopsin A, B and analogs and as novel angiogenesis inhibitors Grant 8,168,657 - Bowen , et al. May 1, 2	2012-05-01
Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states Grant 7,872,029 - Bowen , et al. January 18, 2	2011-01-18
Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states App 20090018167 - Bowen; J. Phillip ; et al.	2009-01-15
Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states Grant 7,432,303 - Bowen , et al. October 7, 2	2008-10-07
Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states App 20050148599 - Bowen, J. Phillip ; et al.	2005-07-07
Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states Grant 6,906,105 - Bowen , et al. June 14, 2	2005-06-14
Solenopsin a, b and analogs and as novel angiogenesis inhibitors App 20050038071 - Bowen, J. Phillip ; et al.	2005-02-17
Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states App 20030027830 - Bowen, J. Phillip ; et al.	2003-02-06
Chalcone and its analogs as agents for the inhibition of angiogensis and related disease states Grant 6,462,075 - Bowen , et al. October 8, 2	2002-10-08
Solenopsin derivatives and analogues as fire ant suppressants Grant 6,369,078 - Bowen , et al. April 9, 2	2002-04-09
Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states App 20020040029 - Bowen, J. Phillip ; et al.	2002-04-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.